Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 416, pseudogene (RN7SL416P)

Target
RN7SL416P
Molecular classification
Other, Pseudogene, Non-coding RNA (pseudogene)
01

Overview

RN7SL416P is a **pseudogene** derived from the 7SL RNA gene family, specifically annotated as "RNA, 7SL, cytoplasmic 416, pseudogene"[1][5][6][7]. The 7SL RNA itself is a structural component of the signal recognition particle (SRP), which is essential for protein targeting to the endoplasmic reticulum in eukaryotic cells[3][4]. However, RN7SL416P, as a pseudogene, is a non-functional remnant of a formerly active gene. It does not encode a functional RNA molecule or protein and is not considered an active participant in cellular processes[1][5][6][7]. Pseudogenes such as RN7SL416P are widespread in the human genome and result from the integration of copied or mutated 7SL RNA sequences that have lost the ability to generate a functional RNA transcript[5][6]. RN7SL416P is not recognized or used as a therapeutic target and has no known biological or pharmacological relevance[1][5][6][7]. RN7SL416P is an example of a **pseudogene** and should not be considered a molecular target for drug development, therapeutic intervention, or biomarker research.

Other names
RN7SL416PRNA, 7SL, cytoplasmic 416, pseudogene
02

Mechanism of action

None

03

Biological functions

None (pseudogene; does not code for functional molecule)
04

Disease associations

None established (no direct disease implication for this specific pseudogene)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 416, pseudogene (RN7SL416P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 416, pseudogene (RN7SL416P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call